Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels-Reference-Cited by-同舟云学术

Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels

Published:2014 Issue:3 Volume:61 Page:249-256
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Aoki Kazutaka¹²,Kamiyama Hiroshi²,Masuda Kiyomi²,Kamiko Kazunari²,Noguchi Yoshihiko²,Tajima Kazuki²,Terauchi Yasuo²

Affiliation:

1. Department of Biostatistics and Epidemiology, Yokohama City University Hospital, Yokohama 236-0004, Japan

2. Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/61/3/61_EJ13-0399/_pdf

Reference35 articles.

1. 1. Aoki K, Kato H, Terauchi Y (2007) Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men. Endocr J 54: 1009-1014.

2. 2. Aoki K, Ito Y, Saito K, Shirakawa J, Togashi Y, et al. (2009) Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose tolerance. Diabetes Res Clin Pract 83: e31-32.

3. 3. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, et al. (2002) STOP-NIDDM Trail Research Group: Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial: Lancet 359: 2072-2077.

4. 4. Kawamori R, Tajima N, Iwamoto Y, Kashiwagi A, Shimamoto K, et al. (2009) Voglibose Ph-3 Study Group: Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance. Lancet 373: 1607-1614.

5. 5. Narita T, Katsuura Y, Sato T, Hosoba M, Fujita H, et al. (2009) Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients. Diabet Med 26: 187-188.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin Sustained-Release and Vildagliptin Fixed-Dose Combination for Optimizing Glycemic Control: A Review with Real-World Case Reports;Clinics and Practice;2023-03-28

2. Callyspongia spp.: Secondary Metabolites, Pharmacological Activities, and Mechanisms;Metabolites;2023-02-01

3. Molecular Pharming;Cisgenics and Transgenics;2022

4. Potential Role of Hypothalamic and Plasma Ghrelin in the Feeding Behavior of Obese Type 2 Diabetic Rats with Intraventricular Glucagon-Like Peptide-1 Receptor Agonist Intervention;Obesity Facts;2020-12-18

5. Usefulness of antidiabetic alpha-glucosidase inhibitors: a review on the timing of administration and effects on gut hormones;Endocrine Journal;2019